Nordea Investment Management AB Grows Stake in Danaher Corporation $DHR

Nordea Investment Management AB boosted its position in shares of Danaher Corporation (NYSE:DHR) by 4.6% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 1,844,686 shares of the conglomerate’s stock after acquiring an additional 81,106 shares during the quarter. Nordea Investment Management AB owned 0.26% of Danaher worth $350,140,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of DHR. Intech Investment Management LLC lifted its stake in shares of Danaher by 46.8% in the 1st quarter. Intech Investment Management LLC now owns 14,591 shares of the conglomerate’s stock worth $2,991,000 after purchasing an additional 4,653 shares during the period. Modern Wealth Management LLC increased its holdings in Danaher by 42.7% during the first quarter. Modern Wealth Management LLC now owns 1,521 shares of the conglomerate’s stock valued at $312,000 after buying an additional 455 shares during the last quarter. Thurston Springer Miller Herd & Titak Inc. raised its position in Danaher by 15.0% in the second quarter. Thurston Springer Miller Herd & Titak Inc. now owns 6,802 shares of the conglomerate’s stock worth $1,344,000 after acquiring an additional 888 shares during the period. Parallel Advisors LLC boosted its stake in shares of Danaher by 9.9% during the 2nd quarter. Parallel Advisors LLC now owns 19,141 shares of the conglomerate’s stock worth $3,781,000 after acquiring an additional 1,732 shares during the last quarter. Finally, Apella Capital LLC grew its position in shares of Danaher by 4.1% during the 2nd quarter. Apella Capital LLC now owns 2,261 shares of the conglomerate’s stock valued at $451,000 after acquiring an additional 89 shares during the period. Institutional investors own 79.05% of the company’s stock.

Insider Transactions at Danaher

In other Danaher news, SVP Brian W. Ellis sold 21,776 shares of Danaher stock in a transaction that occurred on Wednesday, November 12th. The stock was sold at an average price of $219.23, for a total value of $4,773,952.48. Following the sale, the senior vice president owned 14,553 shares of the company’s stock, valued at $3,190,454.19. The trade was a 59.94% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Teri List sold 3,298 shares of the company’s stock in a transaction that occurred on Tuesday, November 18th. The stock was sold at an average price of $226.50, for a total value of $746,997.00. Following the sale, the director directly owned 20,762 shares in the company, valued at $4,702,593. This trade represents a 13.71% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 30,248 shares of company stock valued at $6,609,663. 11.20% of the stock is currently owned by insiders.

Danaher Trading Up 0.4%

Shares of DHR opened at $239.22 on Tuesday. The firm has a market cap of $168.97 billion, a P/E ratio of 49.32, a price-to-earnings-growth ratio of 4.24 and a beta of 0.89. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.52 and a quick ratio of 1.10. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $258.23. The company has a 50 day simple moving average of $226.27 and a two-hundred day simple moving average of $210.94.

Danaher (NYSE:DHR) last issued its earnings results on Monday, October 20th. The conglomerate reported $1.89 earnings per share for the quarter, topping analysts’ consensus estimates of $1.72 by $0.17. The firm had revenue of $6.05 billion during the quarter, compared to analyst estimates of $6 billion. Danaher had a net margin of 14.44% and a return on equity of 10.92%. Danaher’s revenue for the quarter was up 4.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.71 earnings per share. On average, equities analysts expect that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Friday, December 26th will be given a dividend of $0.32 per share. The ex-dividend date is Friday, December 26th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.5%. Danaher’s dividend payout ratio (DPR) is presently 26.39%.

Analyst Ratings Changes

A number of brokerages recently commented on DHR. JPMorgan Chase & Co. raised their target price on Danaher from $260.00 to $270.00 and gave the stock an “overweight” rating in a report on Wednesday, October 22nd. Cowen reaffirmed a “buy” rating on shares of Danaher in a research note on Wednesday, January 7th. Rothschild & Co Redburn reiterated a “neutral” rating and set a $220.00 price objective (down from $245.00) on shares of Danaher in a research note on Wednesday, October 8th. Wells Fargo & Company increased their target price on shares of Danaher from $230.00 to $240.00 and gave the stock an “equal weight” rating in a report on Monday, December 15th. Finally, Robert W. Baird set a $247.00 target price on shares of Danaher in a research note on Wednesday, October 22nd. Twenty-one investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $249.92.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.